Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-001096-43Phase 2Completed
A Phase 2 trial of sirolimus in vascular malformation, slow-flow vascular malformation, sponsored by CHRU Tours. Started Jul 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-001096-43.